Evidence Review
Phytochemical Characterization (García-Ruiz et al., 2017)
García-Ruiz and colleagues published the first systematic phytochemical analysis of guayusa as a commercial tea product [1]. Using HPLC-DAD-ESI-MS, they identified 14 phenolic compounds and five carotenoids in guayusa leaves. Chlorogenic acid and quercetin-3-O-hexose were quantitatively dominant among the phenolics, while lutein was the most concentrated carotenoid. Antioxidant capacity measured by DPPH and ORAC assays confirmed high radical-scavenging activity consistent with the chlorogenic acid content.
The study situated guayusa within the emerging category of caffeinated botanical beverages and provided a composition baseline for comparing guayusa to established teas. The carotenoid content is notable given that few hot-brewed beverages contribute meaningful lutein intake.
Antioxidant and Anti-inflammatory Activity vs. Green and Black Tea (Pardau et al., 2017)
Pardau et al. conducted the most direct comparison of guayusa with conventional teas using standardized in vitro and cellular assay models [2]. Three guayusa tea preparations (varying brew strength and temperature) were compared against green and black Camellia sinensis teas. Total polyphenolic content of guayusa ranged from 54–67 mg GAE per gram dry mass, roughly half the values seen in green tea but within the range of some black tea preparations.
In the Caco-2 cellular antioxidant assay — which measures protection against peroxyl radical damage inside intestinal cells — guayusa afforded 60–80% protection, comparable to the Camellia sinensis preparations. Anti-inflammatory activity was assessed by measuring nitric oxide production in LPS-stimulated RAW 264.7 macrophages. Guayusa reduced nitric oxide by 10–30%, broadly similar to the green and black teas tested.
The key mechanistic distinction: guayusa's antioxidant activity is primarily driven by caffeoylquinic acid derivatives (mono- and dicaffeoylquinic acids identified by mass spectrometry), not catechins. This means it may access antioxidant pathways that are distinct from EGCG-mediated mechanisms of green tea.
Safety Review (Wise and Negrin, 2020)
This critical review analyzed guayusa's ethnobotanical history, chemical profile, and toxicological data as part of a novel food safety assessment for the European market [3]. Key conclusions:
- Guayusa has been consumed continuously in Ecuador for at least several hundred years, with no documented historical adverse effects
- Acute and chronic toxicology studies in rodents showed no genotoxicity, mutagenicity, or organ-level harm at doses far exceeding normal dietary intake
- The methylxanthine, chlorogenic acid, and flavonoid profile presents no known risks beyond those associated with caffeine itself
- The review recommended standard caffeine advisories (pregnancy, caffeine sensitivity) apply equally to guayusa
The authors noted that guayusa's chemical profile is still less thoroughly characterized than green tea, and called for further work on bioavailability and specific effects of its caffeoylquinic acid compounds in humans.
Human Randomized Crossover Trial: Cognitive and Mood Effects (Helwig et al., 2024)
This is the most rigorous human evidence to date for guayusa's cognitive effects [4]. The study enrolled 25 healthy adults (mean age 28, 9 male/16 female) in a randomized, double-blind, placebo-controlled crossover design. Participants received 600 mg GLE, 1,200 mg GLE, or placebo at three separate visits, with a washout between visits.
Outcomes at 60 minutes post-ingestion:
- 600 mg GLE: Significantly lower total mood disturbance (POMS-SF; p < 0.05), reduced fatigue-inertia subscale (p < 0.05), improved perceived energy and focus (p < 0.05), faster choice reaction time (p < 0.05), and faster motor speed (p < 0.05) vs. placebo
- 1,200 mg GLE: Additionally reduced reaction time in a neurocognitive hop test, supporting motor-cognitive benefits at higher doses
- Cardiovascular safety: No significant differences in blood pressure, heart rate, or QT interval vs. placebo at either dose, suggesting the extract does not carry excess cardiovascular risk at these amounts
The study's limitations include a single-visit acute design (no chronic use data), a relatively young and healthy sample, and that the extract concentration may not directly translate to specific amounts of brewed tea. Nonetheless, this is the first placebo-controlled human trial demonstrating dose-dependent cognitive benefits from guayusa supplementation.
Glycemic Effects in an Animal Model (Peçanha de Miranda Coelho et al., 2025)
A Brazilian research group investigated whether guayusa tea could affect glycemia and autonomic cardiovascular control in streptozotocin-induced diabetic female rats [5]. Diabetic rats given guayusa tea ad libitum for 21 days showed improvements in glycemic markers and in sympathovagal cardiovascular balance compared to diabetic controls. Specifically, guayusa was associated with higher values of α1 (a sympathetic modulation index of systolic arterial pressure) and variance in systolic arterial pressure, with a significant inverse correlation between final glucose and vascular variability (r = −0.81, p = 0.002).
These preclinical results suggest guayusa may modulate the autonomic nervous system dysfunction that accompanies chronic hyperglycemia. The study is limited by the animal model (STZ-induced diabetes differs mechanistically from type 2 diabetes) and small sample size (n = 13). Human evidence for guayusa's blood sugar effects is currently lacking.
Overall Evidence Assessment
The evidence base for guayusa is still developing. The antioxidant and anti-inflammatory profile is well-characterized and comparable to green tea in laboratory conditions. Safety data is reassuring. The 2024 human trial establishes plausible cognitive benefits at moderate supplemental doses. Glycemic effects in humans remain unconfirmed.
The strongest practical take: guayusa is a safe and antioxidant-rich caffeinated beverage with a favorable stimulant profile (caffeine + theobromine), meaningfully supported by phytochemical evidence and one well-designed human trial. It is not a replacement for the more extensively studied green tea, but it offers a distinct compound profile and may particularly appeal to those who find coffee or yerba mate too harsh.